NorthEast Myeloma Community Event: New Approaches to Myeloma Treatment with Dr. Giada Bianchi
Join myeloma specialist from Dana Farber Cancer Institute, Dr. Giada Bianchi, as she shares with us the exciting new approaches to myeloma treatment. What has been the standard of care for myeloma? What changes does she see to standard of care myeloma treatment in the near future? Come with your questions and ready to learn.
Audrey introduces the agenda of the event and featured speaker Dr. Giada Bianchi.
Come meet Jeff!
Dr. Giada Bianchi shares with us the exciting new approaches to myeloma treatment.
Type your questions in the chat and we will answer them!
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Dr. Giada Bianchi
Dr. Bianchi is a physician-scientist and Associate Director of the Amyloidosis Program at Brigham and Women’s Hospital/Dana Farber Cancer Institute and Assistant Professor at Harvard Medical School, Boston, MA. She is an associate physician with the Hematology Division of the Brigham and Women’s Hospital. Dr. Bianchi earned her MD degree summa cum laude from Vita-Salute San Raffaele University in Milan, Italy. She trained in Internal Medicine at the Mayo Clinic, Rochester, MN and in Hematology-Oncology at Dana Farber/Partners Cancer Care program in Boston, MA. Dr. Bianchi attends to the care of patients with AL amyloidosis, multiple myeloma, MGUS, MGRS and smoldering myeloma. Her clinical and research expertise is in plasma cell disorders and plasma cell biology. Dr. Bianchi is the recipient of numerous awards, including the Damon Runyon Physician Scientist Training Award, 2016; the Doris Duke Charitable Research Foundation Clinical Scientist Development Award, 2019; the American Society for Clinical Investigation (ASCI) Young Physician-Scientist Award, 2021; and the American Society of Hematology Scholar Award, 2022.